Literature DB >> 25107950

Can biomarkers of disease activity guide treatment in FSGS?

Kirk N Campbell1, John C He2.   

Abstract

Keywords:  focal segmental glomerulosclerosis; glomerular disease; pathology

Mesh：

Substances：

Year:  2014        PMID： 25107950      PMCID： PMC4152810          DOI： 10.2215/CJN.07170714

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  30 in total

Review 1.  Focal segmental glomerulosclerosis.

Authors:  Vivette D D'Agati; Frederick J Kaskel; Ronald J Falk
Journal:  N Engl J Med       Date:  2011-12-22       Impact factor: 91.245

2.  Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients.

Authors:  J M Lorenzen; I Volkmann; J Fiedler; M Schmidt; I Scheffner; H Haller; W Gwinner; T Thum
Journal:  Am J Transplant       Date:  2011-08-03       Impact factor: 8.086

3.  The RNA-binding protein bicaudal C regulates polycystin 2 in the kidney by antagonizing miR-17 activity.

Authors:  Uyen Tran; Lise Zakin; Axel Schweickert; Raman Agrawal; Remziye Döger; Martin Blum; E M De Robertis; Oliver Wessely
Journal:  Development       Date:  2010-04       Impact factor: 6.868

Review 4.  Review: The role of microRNAs in kidney disease.

Authors:  Jordan Yz Li; Tuck Y Yong; Michael Z Michael; Jonathan M Gleadle
Journal:  Nephrology (Carlton)       Date:  2010-09       Impact factor: 2.506

Review 5.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 6.  An update on the treatment options for focal segmental glomerulosclerosis.

Authors:  Alain Meyrier
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

7.  A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

Authors:  Merle Hanke; Kai Hoefig; Hartmut Merz; Alfred C Feller; Ingo Kausch; Dieter Jocham; Jens M Warnecke; Georg Sczakiel
Journal:  Urol Oncol       Date:  2009-04-17       Impact factor: 3.498

8.  MicroRNA-17 post-transcriptionally regulates polycystic kidney disease-2 gene and promotes cell proliferation.

Authors:  Huan Sun; Qing-Wei Li; Xiao-Yan Lv; Jian-Zhong Ai; Qiu-Tan Yang; Jing-Jing Duan; Guo-Hui Bian; Yan Xiao; Yi-Dong Wang; Zheng Zhang; Yu-Hang Liu; Rui-Zhi Tan; Yang Yang; Yu-Quan Wei; Qin Zhou
Journal:  Mol Biol Rep       Date:  2009-10-10       Impact factor: 2.316

9.  MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Authors:  Qiang Wang; Youli Wang; Andrew W Minto; Jinhua Wang; Qun Shi; Xinmin Li; Richard J Quigg
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

10.  miR2Disease: a manually curated database for microRNA deregulation in human disease.

Authors:  Qinghua Jiang; Yadong Wang; Yangyang Hao; Liran Juan; Mingxiang Teng; Xinjun Zhang; Meimei Li; Guohua Wang; Yunlong Liu
Journal:  Nucleic Acids Res       Date:  2008-10-15       Impact factor: 16.971
View more
  1 in total

1.  STAT-3 signaling role in an experimental model of nephropathy induced by doxorubicin.

Authors:  Thabata Caroline de Oliveira Santos; Gabriel Pereira; Anna Gabrielle Gomes Coutinho; Halison Pereira Dos Santos Silva; Marcelo M S Lima; Fernando Augusto Lavezzo Dias; Danilo Cândido de Almeida; Débora Tavares Resende E Silva; Ricardo Fernandez Perez; Rafael Luiz Pereira
Journal:  Mol Cell Biochem       Date:  2022-10-06       Impact factor: 3.842
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.